According to a recent LinkedIn post from Acclaro Medical, the company is highlighting the adoption of its UltraClear laser system by advanced practice nurse Jennifer Rummell of Jenerous Hydration & Wellness. The post relays Rummell’s rationale, emphasizing interest in Laser-Coring technology for traditionally difficult treatment areas such as the neck, hands, arms, knees, and abdomen.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post also notes demand for a gentler alternative to CO2 devices, particularly for younger patients and for procedures that may not require numbing while remaining tolerable. For investors, this suggests incremental uptake of UltraClear in medspa and aesthetic practices, potentially broadening Acclaro Medical’s installed base and recurring revenue opportunities in the energy-based dermatology segment.
The post further underscores use cases tied to “Total Skin Health,” indicating a positioning of UltraClear as a versatile platform rather than a niche device. If this positioning resonates with practitioners seeking multi-area, lower-discomfort treatments, Acclaro Medical could strengthen its competitive footing against other laser and resurfacing systems and enhance long-term practice loyalty.